Aspirin Manufacturer Bayer to Buy Teva’s US Animal Health Business

Sept. 14, 2012

German firm will pay $60 million initially, with a further $85 million tied to agreed manufacturing and sales targets.

German pharmaceuticals giant Bayer (IW 1000/88), best known for its Aspirin painkiller, agreed Friday to buy the U.S. animal health business of Israeli generic drug specialist Teva (IW 1000/243) for $145 million.

The German firm said the deal, which concerns a manufacturing site in St. Joseph, Mo., would "strengthen Bayer HealthCare's companion animal franchise."

Bayer will pay $60 million upfront, with a further $85 million tied to agreed manufacturing and sales targets.

The Missouri site employs a workforce of 300, and the transaction is set to be completed in 2013, pending antitrust clearance, Bayer added.

Copyright Agence France-Presse, 2012

About the Author

Agence France-Presse

Copyright Agence France-Presse, 2002-2024. AFP text, photos, graphics and logos shall not be reproduced, published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP shall not be held liable for any delays, inaccuracies, errors or omissions in any AFP content, or for any actions taken in consequence.